skip to main content
Refined by: List of all Versions remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Review
Add to e-Shelf

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma.

Agulnik, Mark Agulnik, Mark (correspondence author) ; Agulnik, Mark (record owner) March 15, 2012

Cancer, Vol.118(6), pp.1486-1497 [Peer Reviewed Journal]

© ProQuest LLC All rights reserved

Full text available

2
Material Type:
Review
Add to e-Shelf

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

Agulnik, Mark

Cancer, March 15, 2012, Vol.118(6), p.1486(12) [Peer Reviewed Journal]

Cengage Learning, Inc.

Full text available

3
Material Type:
Review
Add to e-Shelf

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

Agulnik, Mark

Cancer, March 15, 2012, Vol.118(6), p.1486(12) [Peer Reviewed Journal]

Cengage Learning, Inc.

Full text available

4
Material Type:
Review
Add to e-Shelf

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

Agulnik, Mark

Cancer, 15 March 2012, Vol.118(6), pp.1486-1497 [Peer Reviewed Journal]

John Wiley & Sons, Inc.

Full text available

5
New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma
Material Type:
Review
Add to e-Shelf

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

Agulnik, Mark

Cancer, 03/15/2012, Vol.118(6), pp.1486-1497 [Peer Reviewed Journal]

Wiley (via CrossRef)

Full text available

6
Material Type:
Review
Add to e-Shelf

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

Agulnik, Mark

Cancer, 15 March 2012, Vol.118(6), pp.1486-97 [Peer Reviewed Journal]

MEDLINE/PubMed (U.S. National Library of Medicine)

Full text available

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait